Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × SCLC × atezolizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 54 Neoplasms 28 Small Cell Lung Carcinoma 23 Melanoma 21 Colorectal Neoplasms 20 Carcinoma, Hepatocellular 20 Carcinoma, Transitional Cell 18 Triple Negative Breast Neoplasms 17 Breast Neoplasms 17 Carcinoma, Renal Cell 16 Urinary Bladder Neoplasms 13 Stomach Neoplasms 11 Neoplasm Metastasis 11 Solid Tumors 9 Squamous Cell Carcinoma of Head and Neck 8 Ovarian Neoplasms 8 Uterine Cervical Neoplasms 7 Lymphoma 7 Head and Neck Neoplasms 6 Lymphoma, Non-Hodgkin 5 Lung Neoplasms 5 Esophageal Neoplasms 5 Advanced Solid Tumor 5 Solid Tumor 4 Pancreatic Neoplasms 4 Liver Neoplasms 4 Leukemia, Myeloid, Acute 4 Carcinoma, Merkel Cell 4 Carcinoma 4 Multiple Myeloma 3

Interventions

Paclitaxel 2 Etoposide 2 Carboplatin 2 sintilimab 1 atezolizumab 1 Topotecan 1 Platinum 1 Drug Therapy 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06179069 2025-08-15

A Study of ZL-1310 in Subjects With Small Cell Lung Cancer

Zai Lab (Hong Kong), Ltd.

Phase 1 Recruiting

SCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡